Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Relapse rate as a major determinant of drug selection in peptic ulcer therapy.

Literature DB >> 3292207

Relapse rate as a major determinant of drug selection in peptic ulcer therapy.

A J McLean¹, D M Harcourt, J J McNeil.

Abstract

Entities: Disease

Mesh：

Substances：
Anti-Ulcer Agents

Year: 1988 PMID： 3292207 DOI： 10.2165/00003495-198835040-00001

Source DB: PubMed Journal: Drugs ISSN： 0012-6667 Impact factor: 9.546

× No keyword cloud information.

20 in total

1. Role of anticholinergic drugs in treatment of peptic ulcer.

Authors: J M RUFFIN; E C TEXTER; D D CARTER; G J BAYLIN
Journal: J Am Med Assoc Date: 1953-11-28

2. A post-investigation of 687 medically treated cases of peptic ulcer.

Authors: H MALMROS; T HIERTONN
Journal: Acta Med Scand Date: 1949

3. Toxic encephalopathy due to ingestion of bismuth salts: clinical and EEG studies of 45 patients.

Authors: V Supino-Viterbo; C Sicard; M Risvegliato; G Rancurel; A Buge
Journal: J Neurol Neurosurg Psychiatry Date: 1977-08 Impact factor: 10.154

4. Relapse rates in duodenal ulcer patients formerly treated with bismuth subcitrate or maintained with cimetidine.

Authors: G Bianchi Porro; M Lazzaroni; M Petrillo; C De Nicola
Journal: Lancet Date: 1984-09-22 Impact factor: 79.321

5. Bacterial colonization and nitrite concentration in the achlorhydric stomachs of patients with primary hypogammaglobulinaemia or classical pernicious anaemia.

Authors: J M Dolby; A D Webster; S P Borriello; F E Barclay; B A Bartholomew; M J Hill
Journal: Scand J Gastroenterol Date: 1984-01 Impact factor: 2.423

6. Relapse rates are more important than healing rates in determining the long-term outcome of duodenal ulcer therapy.

Authors: A J McLean; P M Harrison; A J Byrne; P G McCarthy; F J Dudley
Journal: Gastroenterology Date: 1985-08 Impact factor: 22.682

7. Relative effectiveness and costs of antiulcer medications as a basis for rational prescribing.

Authors: A J McLean; D M Harcourt; P G McCarthy; F J Dudley; J J McNeil
Journal: Med J Aust Date: 1987-04-20 Impact factor: 7.738

8. Model of medical treatment for duodenal ulcer.

Authors: R E Pounder
Journal: Lancet Date: 1981-01-03 Impact factor: 79.321

9. Disposition of metals in rats: a comparative study of fecal, urinary, and biliary excretion and tissue distribution of eighteen metals.

Authors: Z Gregus; C D Klaassen
Journal: Toxicol Appl Pharmacol Date: 1986-08 Impact factor: 4.219

Relapse rate as a major determinant of drug selection in peptic ulcer therapy.

1. Role of anticholinergic drugs in treatment of peptic ulcer.

2. A post-investigation of 687 medically treated cases of peptic ulcer.

3. Toxic encephalopathy due to ingestion of bismuth salts: clinical and EEG studies of 45 patients.

4. Relapse rates in duodenal ulcer patients formerly treated with bismuth subcitrate or maintained with cimetidine.

5. Bacterial colonization and nitrite concentration in the achlorhydric stomachs of patients with primary hypogammaglobulinaemia or classical pernicious anaemia.

6. Relapse rates are more important than healing rates in determining the long-term outcome of duodenal ulcer therapy.

7. Relative effectiveness and costs of antiulcer medications as a basis for rational prescribing.

8. Model of medical treatment for duodenal ulcer.

9. Disposition of metals in rats: a comparative study of fecal, urinary, and biliary excretion and tissue distribution of eighteen metals.

10. Campylobacter pyloridis, urease, hydrogen ion back diffusion, and gastric ulcers.

Review 1. Gastric cytoprotection. What does it really mean for the prescriber?

2. Dopamine agonists prevent duodenal ulcer relapse. A comparative study with famotidine and cimetidine.

3. Lessons for atherosclerosis research from tuberculosis and peptic ulcer.

4. Absorption and elimination of bismuth from oral doses of tripotassium dicitrato bismuthate.